72 related articles for article (PubMed ID: 2577395)
1. Intraperitoneal Vancoled does not cause chemical peritonitis.
Johnson CA; Zimmerman SW; Engeseth S; O'Brien M
Adv Perit Dial; 1989; 5():130-2. PubMed ID: 2577395
[TBL] [Abstract][Full Text] [Related]
2. Chemical peritonitis associated with intraperitoneal vancomycin.
Smith TA; Bailie GR; Eisele G
DICP; 1991 Jun; 25(6):602-3. PubMed ID: 1877269
[TBL] [Abstract][Full Text] [Related]
3. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal Vancoled does not cause chemical peritonitis.
Johnson CA; Zimmerman SW
Perit Dial Int; 1989; 9(3):225. PubMed ID: 2488371
[No Abstract] [Full Text] [Related]
5. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
6. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.
Gadallah MF; Tamayo A; Sandborn M; Ramdeen G; Moles K
Adv Perit Dial; 2000; 16():233-6. PubMed ID: 11045301
[TBL] [Abstract][Full Text] [Related]
7. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
8. Chemical peritonitis following the intraperitoneal administration of vancomycin.
Freiman JP; Graham DJ; Reed TG; McGoodwin EB
Perit Dial Int; 1992; 12(1):57-60. PubMed ID: 1543783
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
[TBL] [Abstract][Full Text] [Related]
10. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
Thomae U; Koblinger S
Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880
[TBL] [Abstract][Full Text] [Related]
11. First exchange neutrophilia is not always an index of peritonitis during CAPD.
Strippoli P; Coviello F; Orbello G; Mingrone G; DiMaggio A; Carelli AM; Oliviero MR; Sebastio AM; Scatizzi A
Adv Perit Dial; 1989; 5():121-3. PubMed ID: 2577392
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
13. A hemostasis study in CAPD patients during fibrinolytic intraperitoneal therapy with urokinase (UK).
Strippoli P; Pilolli D; Mingrone G; Dimaggio A; Coviello F; Orbello G; Querques M; Scatizzi A
Adv Perit Dial; 1989; 5():97-9. PubMed ID: 2577438
[TBL] [Abstract][Full Text] [Related]
14. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
15. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
16. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
18. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
[TBL] [Abstract][Full Text] [Related]
19. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
20. More experience with Vancoled induced chemical peritonitis.
Newman L; Friedlander M; Tessman M
Perit Dial Int; 1990; 10(2):182. PubMed ID: 2085608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
